St. Jude Family of Websites
Explore our cutting edge research, world-class patient care, career opportunities and more.
St. Jude Children's Research Hospital Home
- Fundraising
St. Jude Family of Websites
Explore our cutting edge research, world-class patient care, career opportunities and more.
St. Jude Children's Research Hospital Home
- Fundraising
Brian O'Flynn, PhD
Scientific Writer
Brian O’Flynn, PhD, is a Scientific Writer in the Strategic Communications, Education and Outreach Department at St. Jude.
Stories by Brian O'Flynn
Browsing tumor library sparks understanding of drug resistance in childhood kidney cancer
See how a patient-derived xenograft library is shaping Wilms tumor treatments.
Targeted therapy improvements cap a decade of innovation in spinal muscular atrophy care
See how clinicians are working to bring the best SMA treatment to more patients.
Safeguarding futures by mapping the developing brain
Learn how discoveries in brain development are shaping brighter futures.
Technology advances unlock the mystery of mitochondrial DNA — our “other” genome
See how tools like mitoedit and NETBID reveal mitochondrial DNA (mtDNA) ties to diseases such as acute lymphoblastic leukemia
St. Jude visual artists bring research to life
Watch how St. Jude visual storytellers use artistry to support scientific discovery
The turbulent chemistry behind smarter, safer therapeutics
Explore the ingenuity behind therapeutic optimization
Reducing the risk of posterior fossa syndrome: Questions for Paul Klimo, MD
Neurosurgeon Paul Klimo, MD, explains posterior fossa syndrome, and how surgeons can work to reduce its risk.
Integrated sequencing approach delivers the most reliable pediatric AML diagnosis
See how combining sequencing approaches provides a ‘one-stop shop’ for diagnosing AML.
Genomic Medicine Initiative (GEMINI) targets unmet needs in rare disease treatment
Learn how GEMINI addresses the challenges of rare genetic diseases
Conversations with survivors of cancer guide therapeutic interventions
See how St. Jude gives power to the voices of long-term survivors of childhood cancer